Elevated G6PD increases nucleotide and lipid synthesis, reduces ROS production, and minimizes oxidative damage, thereby promoting cell survival under nutrient starvation and oxaliplatin treatment in CRC, leading to chemoresistance. This evidence concerns the gene G6PD and colorectal carcinoma.